论文部分内容阅读
目的:探讨米索前列醇联合雌激素在绝经女性取出IUD方面所具有的临床效果,并对其特点进行分析。方法:选择我院所接收的需将IUD取出的绝经期女性120例,将其随机分为数量相等的两组,分别作为观察组与对照组,对照组女性未进行任何处理即将IUD取出,观察组中女性在服用米索前列醇加雌激素之后将IUD取出。在取出之后对两组女性的宫颈软化情况以及取出成功率进行比较,并且要对两组女性在手术中的疼痛程度进行比较。结果:在取出之后,对两组女性宫颈软化情况以及取出成功率进行比较,观察组比对照组明显优秀,两组有显著差异存在,比较其术中疼痛程度,两组有显著差异存在。结论:在对绝经女性将IUD取出时,使其服用米索前列醇加雌激素有较好的效果,能够使其宫颈软化率降低,使成功率提高,并且能够使患者痛苦减小,在临床上有重要作用和意义,值得进行推广。
Objective: To investigate the clinical effect of misoprostol combined with estrogen in removing IUD from postmenopausal women and to analyze its characteristics. Methods: 120 cases of postmenopausal women who received IUD in our hospital were selected and randomly divided into two groups of equal numbers, which were taken as the observation group and the control group respectively. The women in the control group were taken out without any treatment and observed Women in the group took the IUD after taking misoprostol plus estrogen. After removal of the two groups of women’s cervical softening situation and the success rate of removal compared to the two groups of women in the surgery to compare the degree of pain. Results: Compared with the control group, the observation group was significantly better than the control group after cervix was taken out. There was significant difference between the two groups. There was a significant difference between the two groups in the degree of pain. CONCLUSIONS: When taking IUD to menopause women, it is better to take misoprostol plus estrogen, which can lower the cervical softening rate, improve the success rate and reduce the patient’s pain. In the clinical On the important role and significance, it is worth promoting.